Nav1.6, encoded by SCN8A, is a major voltage-gated sodium channel isoform at mature axon initial segments and nodes of Ranvier. It supports action potential initiation, high-frequency firing, and reliable long-range conduction in multiple neuronal classes.[1][2] Because Nav1.6 contributes persistent and resurgent sodium current components, dysregulation can strongly alter network excitability and neurotoxicity risk.[2:1][3]
Nav1.6 uses the conserved Nav alpha-subunit architecture (DI-DIV, each with S1-S6 helices) and the canonical fast-inactivation machinery.[1:1] Functionally important features include:
Anchoring interactions (including ankyrin-associated complexes) help establish high channel density at spike-initiation zones.[4]
In healthy adult brain and spinal circuits, Nav1.6 is central for:
These properties are essential for corticospinal output, cerebellar timing, and cortico-hippocampal information flow.
De novo SCN8A variants can cause severe developmental and epileptic encephalopathy. Many pathogenic variants increase channel activity (gain-of-function), producing persistent current and neuronal hyperexcitability.[5][6]
Motor neurons in ALS show hyperexcitability phenotypes in at least a subset of disease stages, and Nav1.6 has been implicated as a potential contributor to excitotoxic stress amplification.[7][8] The mechanistic model is plausible but remains heterogeneous across cohorts and disease phases.
In Alzheimer's disease, epileptiform activity and neuronal network instability are common. While Nav1.6 is not established as a primary pathological driver, sodium-channel remodeling may contribute to vulnerable-circuit overactivity, especially when inhibitory buffering is reduced.[9][10]
Broad sodium-channel blockers can reduce hyperexcitability but may impair normal signaling and cognition if over-suppressed.[11] Isoform-selective Nav1.6 strategies are of interest but still limited in clinical maturity.
In SCN8A encephalopathy, variant-level functional annotation increasingly guides treatment choice, as some genotypes respond better to specific channel-modulating regimens.[6:1][11:1]
For degenerative diseases, Nav1.6-targeted interventions likely require biomarker stratification (for example, electrophysiologic hyperexcitability signatures) rather than broad empiric use.[8:1][10:1]
Evidence is strongest for SCN8A monogenic epileptic disease, moderate for Nav1.6 involvement in acquired hyperexcitability, and exploratory for direct disease modification in chronic neurodegeneration.[5:1][8:2][10:2]
Open questions:
Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacological Reviews. 2005. ↩︎ ↩︎
Rush AM, Dib-Hajj SD, Waxman SG. Electrophysiological properties of sodium channels in neurons and their pathophysiological roles. Physiological Reviews. 2005. ↩︎ ↩︎ ↩︎ ↩︎
Raman IM, Bean BP. Resurgent sodium current and action potential generation in neurons. Neuron. 2001. ↩︎ ↩︎
Hu W, Tian C, Li T, et al. Distinct contributions of Nav1.6 and Nav1.2 in action potential initiation and backpropagation. Nature Neuroscience. 2009. ↩︎ ↩︎
Veeramah KR, O'Brien JE, Meisler MH, et al. De novo pathogenic SCN8A mutation identified by exome sequencing of a proband with epileptic encephalopathy. Nature Genetics. 2012. ↩︎ ↩︎
Gardella E, Moller RS. Phenotypic and therapeutic landscape of SCN8A-related epilepsy. Epilepsia. 2019. ↩︎ ↩︎
Wainger BJ, Kiskinis E, Mellin C, et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Reports. 2014. ↩︎
Martinez-Silva ML, Imhoff-Manuel RD, Sharma A, et al. Hypoexcitability precedes denervation in ALS model and reveals stage-specific electrophysiologic changes. Journal of Neuroscience. 2018. ↩︎ ↩︎ ↩︎
Vossel KA, Beagle AJ, Rabinovici GD, et al. Seizures and epileptiform activity in early Alzheimer's disease. JAMA Neurology. 2013. ↩︎
Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nature Reviews Neuroscience. 2016. ↩︎ ↩︎ ↩︎
Catterall WA. Sodium channels, inherited epilepsy, and antiepileptic therapy. Annual Review of Pharmacology and Toxicology. 2020. ↩︎ ↩︎